论文部分内容阅读
目的:采用开放标签式试验,研究口服特比萘芬治疗真菌性足菌肿的临床疗效和安全性。方法:纳入27例在5年内发病的具有足菌肿的症状和体征、并经真菌学检测确诊的患者,进行单中心、开放标签的研究。对意向治疗的23例患者给予特比萘芬500 mg每次、每天2次,连续服用24-48周。在第24周进
OBJECTIVE: To study the clinical efficacy and safety of oral terbinafine in the treatment of fungal mycobacteria by open label test. Methods: 27 single-center, open-label studies were enrolled in 27 patients with pathogenic bacteria that developed symptoms within 5 years and were confirmed by mycological tests. Twenty-three patients receiving intentional therapy were given terbinafine 500 mg twice daily for 24-48 weeks. Enter the 24th week